Dr.Liesbet Vermeiren, radiologie en Dr. Karel Carpentier, orthopedische heelkunde
0697.568.372 · rovalta.com · 28/09/2026
Dr.Liesbet Vermeiren, radiologie en Dr. Karel Carpentier, orthopedische heelkunde
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBODr.Liesbet Vermeiren, radiologie en Dr. Karel Carpentier, orthopedische heelkunde is a Private limited company incorporated in 2018. Its registered office is in Antwerpen.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0697.568.372
- Incorporation
- 01/06/2018
- Legal form
- Private limited company
- Registered office
- Vijverlaan 9
2610 Antwerpen · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 8 filingsTrend over 7 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 666,4 k € | +3.7% | 642,4 k € | +16.7% | 550,3 k € | +2.7% | 535,8 k € | +19.2% | 449,4 k € |
| EBITDA | 647,4 k € | +1.7% | 636,3 k € | +15.9% | 549 k € | +2.9% | 533,8 k € | +19.2% | 448 k € |
| Operating result | 543,1 k € | -0.3% | 544,5 k € | +34.8% | 403,8 k € | -8.8% | 442,9 k € | +23.4% | 358,9 k € |
| Net result | 393,7 k € | +1.2% | 388,9 k € | +30.8% | 297,2 k € | -9.3% | 327,9 k € | +25.3% | 261,8 k € |
| Balance sheet | |||||||||
| Equity | 20,5 k € | -95.0% | 409,4 k € | +28.5% | 318,6 k € | -8.5% | 348,3 k € | -49.8% | 693,9 k € |
| Total assets | 1,5 M € | +9.4% | 1,4 M € | +20.7% | 1,1 M € | +6.8% | 1,1 M € | -28.5% | 1,5 M € |
| Cash | 312,7 k € | -40.4% | 524,9 k € | +4431% | 11,6 k € | -97.2% | 407 k € | -50.6% | 823,2 k € |
| Debts | 1,5 M € | +54.5% | 944,9 k € | +17.1% | 806,6 k € | +14.7% | 703,4 k € | -9.7% | 779,1 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20252 active · 1 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Karel Carpentier | Directorsince 18/06/2020 | ||
Liesbet Vermeiren | Directorsince 01/06/2018 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Liesbeth Vermeiren | Manager2019 accounts |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 27/04/2026 | 29/08/2025 | 30/08/2024 | 20/09/2023 | 23/08/2022 | 28/08/2021 |
| General meeting | 27/04/2026 | 17/05/2025 | 18/05/2024 | 20/05/2023 | 20/05/2022 | 21/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 8 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 27/04/2026 | 27/04/2026 | Dutch | |
| Micro model | 31/12/2024 | 17/05/2025 | 29/08/2025 | Dutch | |
| Micro model | 31/12/2023 | 18/05/2024 | 30/08/2024 | Dutch | |
| Micro modelCorrection | 31/12/2022 | 20/05/2023 | 20/09/2023 | Dutch | |
| Micro model | 31/12/2022 | 20/05/2023 | 31/08/2023 | Dutch | |
| Micro model | 31/12/2021 | 20/05/2022 | 23/08/2022 | Dutch | |
| Micro model | 31/12/2020 | 21/05/2021 | 28/08/2021 | Dutch | |
| Micro model | 31/12/2019 | 15/05/2020 | 16/07/2020 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active · 1 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Karel Carpentier | Directorsince 18/06/2020 | ||
Liesbet Vermeiren | Directorsince 01/06/2018 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Liesbeth Vermeiren | Manager2019 accounts |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Vijverlaan 9, 2610 Wilrijk (Antwerp)Current | accounts 2021 → 2025 | Accounts 2025 · 2026-00090100 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Dr.Liesbet Vermeiren, radiologie en Dr. Karel Carpentier, orthopedische heelkundeCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00090100 |
Events
- 2025Annual accounts 2025393,7 k €↑
- 2024Annual accounts 2024388,9 k €↑
- 2023Annual accounts 2023297,2 k €↓
- 2022Annual accounts 2022327,9 k €↑
- 2021Annual accounts 2021261,8 k €↑
- 2020Annual accounts 2020192,6 k €↓
- 2019Annual accounts 2019220,9 k €
- 01/06/2018IncorporationPrivate limited company